Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $23.80 Average Target Price from Analysts
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month target […]
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month target […]
